Literature DB >> 7988197

Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients.

H Hamm1, J Lührs, J Guzman y Rotaeche, U Costabel, H Fabel, W Bartsch.   

Abstract

Interstitial lung diseases often are accompanied by histopathologic evidence of alveolar type 2 cell alterations. In the alveolar milieu, the surfactant-specific protein A (SP-A) is a secretory product of alveolar type 2 cells. Therefore, we measured SP-A levels in bronchoalveolar lavage (BAL) fluids from patients with untreated sarcoidosis (n = 35) and hypersensitivity pneumonitis (HP [n = 10]) and compared the results with those from 21 healthy control subjects. In sarcoidosis patients, SP-A was markedly higher than in control subjects with a mean of 8.0 micrograms/ml of recovered BAL fluid +/- 0.7 SEM (p < 0.0001 compared with control subjects). In HP, SP-A values were comparable with those in sarcoidosis with a mean of 9.0 micrograms/ml +/- 1.7 SEM. Mean SP-A in the control group was 4.0 micrograms/ml +/- 0.3 SEM. These results suggest that SP-A secretion is stimulated in sarcoidosis and HP. Further studies seem justified to investigate the role of the surfactant system in interstitial lung diseases as well as the potential clinical usefulness of SP-A measurements in BAL.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988197     DOI: 10.1378/chest.106.6.1766

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

Review 1.  The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.

Authors:  SeungHye Han; Rama K Mallampalli
Journal:  Ann Am Thorac Soc       Date:  2015-05

2.  Effect of contact avoidance or treatment with oral prednisolone on bronchoalveolar lavage surfactant protein A levels in subjects with farmer's lung.

Authors:  Y Cormier; E Israël-Assayag; M Desmeules; O Lesur
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

3.  Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans.

Authors:  A M Karinch; D E deMello; J Floros
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

4.  Cap-independent translation of human SP-A 5'-UTR variants: a double-loop structure and cis-element contribution.

Authors:  Guirong Wang; Xiaoxuan Guo; Patricia Silveyra; Scot R Kimball; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-30       Impact factor: 5.464

5.  Exon B of human surfactant protein A2 mRNA, alone or within its surrounding sequences, interacts with 14-3-3; role of cis-elements and secondary structure.

Authors:  Georgios T Noutsios; Patricia Silveyra; Faizah Bhatti; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-22       Impact factor: 5.464

Review 6.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 7.  Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury.

Authors:  Patricia Silveyra; Joanna Floros
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 8.  Lung surfactant in subacute pulmonary disease.

Authors:  Gehan Devendra; Roger G Spragg
Journal:  Respir Res       Date:  2002-04-04

Review 9.  Surfactant gene polymorphisms and interstitial lung diseases.

Authors:  Panagiotis Pantelidis; Srihari Veeraraghavan; Roland M du Bois
Journal:  Respir Res       Date:  2001-11-29

10.  On the significance of Surfactant Protein-A within the human lungs.

Authors:  Torsten Goldmann; Daniel Kähler; Holger Schultz; Mahdi Abdullah; Dagmar S Lang; Florian Stellmacher; Ekkehard Vollmer
Journal:  Diagn Pathol       Date:  2009-03-12       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.